ArticleMolecules (Basel, Switzerland)2025
Strong Nucleating Effect of Si-Containing Tri-Block Oligomers on Poly(Ethylene Terephthalate).
Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The development of a silane coupling agent with an aminopropyl structure as a nucleating agent for poly(ethylene terephthalate) (PET) is reported in this study. The tri-block oligomers nucleating agent was formed by 1,3-bis(3-aminopropyl)-1,1,3,3-tetramethyldisiloxane/oxalic acid/low molecular weight PET (LPOBD). It was subsequently cross-linked with tetraethyl orthosilicate to form LPOBD-T. Composites of LPOBD/PET and LPOBD-T/PET were prepared by melt blending, and their thermal and crystallization behaviors were analyzed using XRD, DSC, TG, and POM. The results indicated that not only did the triblock polymer nucleating agent LPOBD exhibit a strong nucleation effect, but the crosslinked LPOBD-T also demonstrated superior crystallization performance. Specifically, the crystallinity of the 1 wt% LPOBD-T/PET composite increased by 3.3%, the crystallization temperature rose by 21.1 °C, and the t
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.